Advertisement
Advertisement

UTHR

UTHR logo

United Therapeutics Corp

485.68
USD
Sponsored
+6.75
+1.41%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

485.63

-0.06
-0.01%

UTHR Earnings Reports

Positive Surprise Ratio

UTHR beat 20 of 40 last estimates.

50%

Next Report

Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$832.86M
/
$7.00
Implied change from Q3 25 (Revenue/ EPS)
+4.17%
/
-2.23%
Implied change from Q4 24 (Revenue/ EPS)
+13.18%
/
+13.09%

United Therapeutics Corp earnings per share and revenue

On Oct 29, 2025, UTHR reported earnings of 7.16 USD per share (EPS) for Q3 25, missing the estimate of 7.33 USD, resulting in a -2.35% surprise. Revenue reached 799.50 million, compared to an expected 831.21 million, with a -3.82% difference. The market reacted with a +9.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of 7.00 USD, with revenue projected to reach 832.86 million USD, implying an decrease of -2.23% EPS, and increase of 4.17% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, United Therapeutics Corp reported EPS of $7.16, missing estimates by -2.35%, and revenue of $799.50M, -3.82% below expectations.
The stock price moved up 9.63%, changed from $415.34 before the earnings release to $455.32 the day after.
The next earning report is scheduled for Feb 25, 2026.
Based on 15 analysts, United Therapeutics Corp is expected to report EPS of $7.00 and revenue of $832.86M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement